Pursuant to section 106 (1) of the Medicines Act 1981, I,
G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:
1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) Preparations and admixtures containing any proportion of any substance listed in the notice;
(b) Salts and esters of any substance listed in the notice;
(c) Preparations or extracts of biological materials listed in the notice;
(d) Salts or oxides of elements listed in the notice.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule 1
Prescription Medicines
abacavir
alkyl sulfonals
amphomycin
androisoxazole
azelaic acid; except for dermal use
bicalutamide
bolandiol
bolasterone
bolazine
boldenone (dehydrotestosterone)
bolenol
bolmantalate
butylchloral hydrate
4-chloromethandienone
calusterone
candicidin
captodiame
capuride
cefacetrile
cefaloridine
cefapirin
chloralformamide
chloral hydrate; except in topical preparations containing 2% or less
chloralose
chlorandrostenolone
chloroform; for use in anaesthesia; except when specified elsewhere in the Schedules
chloroxydienone
chloroxymesterone (dehydrochloromethyltestosterone)
clocortolone
clofenamide
clomocycline
clostebol (4-chlorotestosterone)
corticosterone
cyclothiazide
2,4-dinitrochlorobenzene
dehydrocorticosterone
desoximetasone
dextromethorphan; except when specified elsewhere in the Schedules
diethylcarbamazine
diflorasone
dihydrolone
dimethandrostanolone
dimethazine
edetic acid; except dicobalt edetate in preparations for the treatment of cyanide poisoning
enestebol
enflurane
epitiostanol
ethanolamine; in medicines for injection
ether; for use in anaesthesia
ethyl chloride; for inhalational anaesthesia
ethyldienolone
fluclorolone
fluocortin
formebolone
formyldienolone
furazabol
hetacillin
hydroxystenozol
ivermectin
lauromacrogol; in medicines for injection
mebolazine
mepitiostane
mercury; except when specified elsewhere in the Schedules
mesabolone
mestanolone (androstalone)
methacycline
methandienone
methandriol
methenolone
methyl androstanolone
methyl clostebol
methyl trienolone
metolazone
metribolone
mibolerone
mirtazapine
mitobronitol
mitomycin
mupirocin
niridazole
norandrostenolone
norbolethone
norclostebol
norethandrolone
oleandomycin
ovandrotone
oxabolone
oxacillin
oxetacaine; except for internal use
oxymesterone
paramethasone
paromomycin
pentosan polysulfate sodium
pertussis antigen
phenacemide
pheneticillin
phenol; in medicines for injection
pipobroman
prasterone (dehydroepiandrosterone, dehydroisoandrosterone)
praziquantel
procaine penicillin
propetandrol
quinbolone
quinethazone
raloxifene
raltitrexed
roxibolone
silandrone
sodium cellulose phosphate
sodium morrhuate; in medicines for injection
sodium oxybate
stanolone
stanozolol
stenbolone
sulfamonomethoxine
sulfatroxazole
sulfomyxin
sulfonmethane
teropterin
testolactone
thiambutosine
thiazosulfone
thioacetazone
tolonium
triclofos
trimustine
urethane (excluding its derivatives)
valnoctamide
viprinium
virginiamycin
Schedule 2
Restricted Medicines
clotrimazole; for vaginal use
econazole; for vaginal use
folinic acid (leucovorin)
isoconazole; for vaginal use
leucovorin (folinic acid)
miconazole; for vaginal use
nystatin; for vaginal use
tioconazole; for vaginal use
Schedule 3
Pharmacy-only Medicines
azelaic acid; for dermal use
chloroform; in medicines other than for anaesthesia containing more than 0.5%
cresols; in medicines containing more than 3%
dextromethorphan; in liquid form containing more than 0.25% and not more than 0.3% and in solid dose form containing more than 15 milligrams and not more than 30 milligrams per dose form.
ether; in medicines other than for anaesthesia containing more than 10%
mercury; in topical preparations containing 0.5% or less
oxetacaine; for internal use
phenol; in medicines other than for injection containing more than 3%
xylenols; in medicines containing more than 3%
Medicines for General Sale
Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.
chloral hydrate; in topical preparations containing 2% or less
chloroform; in medicines other than for anaesthesia containing 0.5% or less
cresols; in medicines containing 3% or less
dextromethorphan; in liquid form containing 0.25% or less and in solid dose form containing 15 milligrams or less per dose form
edetic acid; in preparations containing dicobalt edetate for the treatment of cyanide poisoning
ether; in medicines other than for anaesthesia containing 10% or less
phenol; in medicines other than for injection containing 3% or less
xylenols; in medicines containing 3% or less
Dated this 30th day of June 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation.